longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Pro-Dex

PDEX

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 17.00, within the reasonable range, cheaper than 48.08% of the time in the past 3 years, and the industry ranks 9/175, the industry Median -0.94.

17xP/E
$72.52Stock price
$4.26Earnings per share
17xP/E
Stock price$72.52Earnings per share$4.26

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
16.69x
Typical range
12.16x–29.61x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
MDTUSMedtronic
22.44x26.73%$117.36B
SYKUSStryker
28.20x53.15%$105.17B
BSXUSBoston Scientific
17.25x36.31%$63.36B
RMDUSResmed
21.18x11.93%$32.26B
RYLPFUSKoninklijke Philips N.V.
17.79x--$23.01B
PHGUSKoninklijke Philips Elect
18.82x16.23%$24.34B
TRUMYUSTerumo
19.92x--$20.93B
STEUSSteris
25.07x17.10%$20.18B
ZBHUSZimmer Biomet
22.30x37.01%$17.99B
SNNUSSmith and Nephew
18.34x42.74%$11.65B
GMEDUSGlobus Medical Inc
18.63x6.02%$9.97B
PODDUSInsulet
25.97x76.42%$9.75B
SSMXYUSSysmex
28.35x--$7.17B
LIVNUSLivanova
22.84x189.82%$4.31B
TMDXUSTransMedics
19.95x71.39%$3.03B
INSPUSInspire Medical
16.21x100.86%$2.19B
LMATUSLemaitre Vascular
27.55x13.99%$1.81B
CNMDUSConmed
23.69x156.95%$1.34B
TCMDUSTactile
20.82x36.59%$517.60M
BWAYUSBrainsway
28.15x70.37%$265.77M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.